Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, announces that it has completed its previously announced transaction to acquire Owen Mumford Holdings Limited (“Owen Mumford”), a privately held, UK-based innovator and manufacturer of medical devices and drug delivery technologies. On March 19, 2026, the two companies announced a definitive agreement for embecta to acquire Owen Mumford for an upfront cash payment of £100 million and up to an additional £50 million in performance-based payments based on net sales of the Aidaptus® next generation auto-injector platform in the three-year period following the closing.
Read the full article: embecta Completes Acquisition of Owen Mumford Holdings Limited //
Source: https://www.globenewswire.com/news-release/2026/05/15/3295891/0/en/embecta-Completes-Acquisition-of-Owen-Mumford-Holdings-Limited.html